Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Gyre Therapeutics (GYRE) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to $90.9 million.

  • Gyre Therapeutics' Shares Outstanding rose 597.05% to $90.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.9 million, marking a year-over-year increase of 597.05%. This contributed to the annual value of $86.3 million for FY2024, which is 1267.95% up from last year.
  • Per Gyre Therapeutics' latest filing, its Shares Outstanding stood at $90.9 million for Q3 2025, which was up 597.05% from $90.8 million recorded in Q2 2025.
  • Gyre Therapeutics' Shares Outstanding's 5-year high stood at $90.9 million during Q3 2025, with a 5-year trough of $31.3 million in Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding was $63.6 million (2021), whereas its average is $62.9 million.
  • In the last 5 years, Gyre Therapeutics' Shares Outstanding soared by 18775.74% in 2021 and then changed by 0.0% in 2022.
  • Over the past 5 years, Gyre Therapeutics' Shares Outstanding (Quarter) stood at $63.6 million in 2021, then changed by 0.0% to $63.6 million in 2022, then grew by 20.46% to $76.6 million in 2023, then increased by 12.68% to $86.3 million in 2024, then grew by 5.31% to $90.9 million in 2025.
  • Its last three reported values are $90.9 million in Q3 2025, $90.8 million for Q2 2025, and $87.6 million during Q1 2025.